POMMICRO

POMDOCTOR Ltd

HealthcareMedical - Pharmaceuticals
$0.49
$0.00(+25.22%)
52W$0.19
$6.43
Updated May 7, 12:00 AM
RSI56
RS Rating64/99
Beta1.45
Volatility206%
F-Score4/9
Mkt Cap$53M
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

POMDOCTOR Ltd is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 64), indicating performance broadly in line with the market. However, price is extended 48% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
64
out of 99
Average
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
1.45
vs S&P 500
ABOVE MKT
52W Position
5%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$0.33
50 SMA > 100 SMA$0.31
100 SMA > 150 SMA$
150 SMA > 200 SMA$

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$0.38+29.35%ABOVE
50 SMA$0.33+48.17%ABOVE
100 SMA$0.31+59.35%ABOVE
150 SMA$
200 SMA$

Price Performance

1D+25.2%
1W+32.9%
1M+104.0%
3M+113.9%
6M-91.9%
YTD+51.5%
1Y-87.7%
3Y-50.3%
52-Week Trading Range5% from low
$0.49
52W Low$0.19
52W High$6.43

Technical Indicators

RSI (14)NEUTRAL
55.6
305070
VCP Score
/10
Base depth: %

Risk Profile

Beta
1.45
52W Vol
206%
ATR
$0.05
Max DD (1Y)
-96%

Volume Analysis

Today
1.79M
50D Avg
1.30M
Vol Ratio
1.38x
Liquidity
ILLIQUID
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:+16.73%
TTM:

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR

10 Years:-18.93%
5 Years:-34.28%
3 Years:-50.32%
1 Year:-87.74%

Return on Equity

10Y Avg:
5Y Avg:
3Y Avg:
Last Year:

Key Metrics

Market Cap$53M
Gross Margin13.9%
Net Margin-41.9%
Piotroski F-Score4/9

Frequently Asked Questions

Is POM in an uptrend right now?

POM has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is POM overbought or oversold?

POM's RSI (14) is 56. The stock is in neutral territory, neither overbought nor oversold.

Is POM outperforming the market?

POM has a Relative Strength (RS) Rating of 64 out of 99. POM is performing about average compared to the market.

Where is POM in its 52-week range?

POM is trading at $0.49, which is 8% of its 52-week high ($6.43) and 5% above its 52-week low ($0.19).

How volatile is POM?

POM has a Beta of 1.45 and 52-week volatility of 206%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.